US approval for abacavir

On December 18^th, the American Food and Drug

Administration licensed Glaxo Wellcome’s nucleoside analogue RT inhibitor

abacavir (Ziagen™) for use in the treatment of HIV-infected adults.

Abacavir is the fifteenth antiretroviral to be approved in the US.

Full, FDA-approved prescribing information and a patient information sheet on

the drug can be found online, including in PDF format, at

Your first name *

Your last name *

Your email address *

Please let us know how you'd like to be contacted by ticking the options below.

Yes, I’d like to receive aidsmap email bulletins to keep up to date with the latest research, news and developments in HIV

Yes, I’d like to receive regular newsletter emails about what Terrence Higgins does

Share this page